home / stock / txg / txg news


TXG News and Press, 10x Genomics Inc. From 01/24/24

Stock Information

Company Name: 10x Genomics Inc.
Stock Symbol: TXG
Market: NYSE
Website: 10xgenomics.com

Menu

TXG TXG Quote TXG Short TXG News TXG Articles TXG Message Board
Get TXG Alerts

News, Short Squeeze, Breakout and More Instantly...

TXG - 10x Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024

10x Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024 PR Newswire PLEASANTON, Calif. , Jan. 24, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced ...

TXG - Top high-quality growth stocks poised to outperform - MS

2024-01-22 11:29:07 ET More on S&P 500 Index: S&P 500 Sets New Record High As Investors Potentially Shift Focus To Q2 2024 Market Rally Met With Outflows S&P 500: The 'Pump' Is Underway - Watch Out For The 'Dump' S&P won't get the helping hand...

TXG - Stocks To Watch: Eyes On Chipmakers, Tesla, Netflix And BrightSpring IPO

2024-01-20 10:00:00 ET Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs, investor days, earnings r...

TXG - 10x Genomics: Still Waiting For Entry

2024-01-20 06:55:00 ET Summary 10x Genomics reported 18% YoY revenue growth in Q4, reaching $184M, with instruments revenue seeing a remarkable surge of 71%. The company celebrated the successful launch of its cutting-edge platform, Xenium, which offers exceptional vision and surp...

TXG - 10x Genomics: Sales Are Growing At A Rapid Rate, But So Are Expenses

2024-01-20 02:20:35 ET Summary 10x Genomics specializes in medical devices and software for analyzing biodata, with impressive revenue growth but struggling to turn a profit. The company's products have been used in over 6,100 medical research publications and have helped create o...

TXG - Catalyst Watch: Tesla, Netflix and Procter & Gamble head into the earnings confessional

2024-01-19 15:00:29 ET More on the markets SPY Is At Its Highest Risk Level (Technical Analysis) Recession Forecasting: Indicators That Actually Help Your Portfolio (Part 3) New Secular Bull Markets Hidden In Plain Sight Investors retract capital from the fun...

TXG - Tracking Cathie Wood's ARK Invest 13F Portfolio - Q4 2023 Update

2024-01-18 21:08:20 ET Summary ARK Invest's 13F portfolio value increased by 29% this quarter, reaching approximately $16.89 billion. The top three holdings in the portfolio are Coinbase Global, UiPath, and Tesla. ARK Invest made new stakes in ProShares Bitcoin Strategy ETF an...

TXG - Torex Gold Provides 2024 Operational Guidance and Updated Five-year Production Outlook

2024 is a pivotal year that sets up for strong continued production and future free cash flow from Morelos (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. - January 16, 2024) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) prov...

TXG - Torex Gold Reports Strong Close to 2023

Production guidance achieved for the fifth consecutive year; Q4 marks second-highest quarter of production to date Toronto, Ontario--(Newsfile Corp. - January 9, 2024) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) reports gold production of 137,993 ounces during the fourth qu...

TXG - 10x Genomics beats prelim q4 revenue expectation

2024-01-08 12:02:16 ET More on 10x Genomics 10x Genomics: Unveiling The Investment Potential 10x Genomics, Inc. (TXG) Q3 2023 Earnings Call Transcript BofA raises 10x Genomics to buy, cites fading headwinds 10x Genomics files patent lawsuit against rival Curi...

Previous 10 Next 10